Authors
Latest:
Outcome Measures for Oncology Alternative Payment Models: Practical Considerations and RecommendationsThis review presents a set of evidence-based outcome measures for oncology alternative payment models, drawing on evidence from existing and proposed quality measures.
Latest:
Cost Sharing for Antiepileptic Drugs: Medication Utilization and Health Plan CostsIncreased out-of-pocket costs for antiepileptic drugs were associated with decreased adherence, higher healthcare utilization, and higher spending among US commercial health plan beneficiaries with epilepsy.
Latest:
Cost Savings in Inpatient Oncology Through an Integrative Medicine ApproachAn approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.
Latest:
Sharing Care in the ACO EraThe authors propose a framework considering patient complexity and certainty of diagnosis to triage encounters to the most appropriate provider in an accountable care organization.
Latest:
Potential Misuse and Inappropriate Prescription Practices Involving Opioid AnalgesicsA quarter of opioid recipients with commercial insurance had at least 1 indicator of potential misuse by patients or inappropriate prescription practices by providers.
Latest:
Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug AdherenceCommercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
Latest:
Mometasone Furoate Versus Beclomethasone Dipropionate: Effectiveness in Patients With Mild AsthmaIn patients with mild asthma, mometasone furoate dry powder inhaler resulted in improved adherence and fewer exacerbations than beclomethasone dipropionate hydrofluoroalkane aerosol inhaler.
Latest:
Effects of an Integrated Medication Therapy Management Program in a Pioneer ACOThis article reports that an integrated medication management program in a Pioneer Accountable Care Organization was associated with decreases in all-cause hospitalization and Medicare costs.
Latest:
Genetic Counselors Save Costs Across the Genetic Testing SpectrumGenetic counselors (GCs) increasingly serve a variety of roles across the healthcare spectrum, including test utilization management. Our data show that utilizing the expertise of GCs reduced test order errors, improved patient outcomes, and resulted in significant cost savings to the healthcare system.
Latest:
The Use of Claims Data Algorithms to Recruit Eligible Participants Into Clinical TrialsUsing an ICD-9-CM code algorithm, the authors effectively identified potentially difficult-to-reach populations for a hypertension clinical trial.
Latest:
What the Data Can-and Can't-Say About PatientsDr. Vojta emphasized the importance of analyzing existing good patient data to improve care outcomes.
Latest:
Process, Cost, and Clinical Quality: The Initial Oral Contraceptive VisitLinking variation in process with cost and quality provides the opportunity for identifying low-cost, high-quality processes.
Latest:
Current Value-Based Care Models Need Greater Emphasis on Specialty CareThis article provides an overview of the impact of specialty care and the opportunity for it to leapfrog primary care as a lead focus for accountable care.
Latest:
Previously Unrecognized Trends in Diabetes Consumption Clusters in MedicareMedicare beneficiaries with diabetes who are at the lowest levels of healthcare consumption often become some of the highest level consumers in subsequent years.
Latest:
Radical Prostatectomy Innovation and Outcomes at Military and Civilian InstitutionsMinimally invasive radical prostatectomy was more commonly performed in civilian hospitals compared with military hospitals among TRICARE beneficiaries, with comparable postoperative outcomes.
Latest:
Patient Outcomes Associated With Tailored Hospital Programs for Intellectual DisabilitiesPatients with intellectual disabilities who were cared for in hospitals without programs tailored to intellectual disabilities had 6% higher costs, and those with extreme admission severity had 42% higher costs.
Latest:
Performance of the Adapted Diabetes Complications Severity Index Translated to ICD-10We present an International Classification of Diseases, Tenth Revision (ICD-10) translation of the adapted Diabetes Complications Severity Index and show its performance in predicting hospitalizations, mortality, and healthcare-associated costs.
